Амлодипин: от базовых клинических исследований к работам сегодняшнего дня (часть 1)

1. Карпов Ю.А. Оптимальное лечение артериальной гипертонии и ишемической болезни сердца: аргументы в пользу комбинации периндоприла аргинина и амлодипина. Consilium Medicum. 2010; 5: 51–6.
2. Meredith PA, Elliott HL. Clinical pharmacokinetics of amlodipine. Clin Pharmacokinet 1992; 22 (1): 22–31.
3. Леонова МВ. Современный взгляд на S-амлодипин и новые препараты S-амлодипина. Рацион. фармакотерапия в кардиологии. 2011; 7 (2): 227–30.
4. Zuo XC, Zhou YN, Zhang BK et al. Effect of CYP3A5*3 polymorphism on pharmacokinetic drug interaction between tacrolimus and amlodipine. Drug Metab Pharmacokinet. 2013; 28 (5): 398–405.
5. Yoshii T, Iwai M, Li Z et al. Regression of Atherosclerosis by Amlodipine via Anti-Inflammatory and Anti-Oxidative Stress Actions. Hypertension Research. 2006; 29: 457–66.
6. Kloner RA, Sowers JR, DiBona et al. Sex – and age related antihypertensive effects of amlodipine. The AaCardiovascular Community Study trial Group. Am J Cardiol 1996; 77 (9): 713–22.
7. Kloner RA, Weinberger M, Pool JL et al. Comparison of Candesartan and Amlodipine for Safety, Tolerability and Eficacy (CASTLE) Study Investigators. Comparative effects of candesartan cilexitil and amlodipine in patients with mild systemic hypertension. Comparison of Candesartan and Amlodipine for Safety, Tolerability and Eficacy (CASTLE) Study Investigators. Am J Cardiol 2001; 87 (6): 727–31.
8. Чазова И.Е., Ратова Л.Г. Комбинированная терапия артериальной гипертонии (итоги международной программы КЛИП-АККОРД). Consilium Medicum. 2009; 11 (5): 12–5.
9. Morgan TO, Andercon AI, MacInnis RJ. ACE Inhibitors, beta-blockers, calcium antagonists, and diuretics for the control of systolic hypertension. Am J Hypertens 2001; 14: 241–7.
10. Недогода СВ. Монотерапия артериальной гипертензии: конец главы или продолжение следует? Consilium Medicum. 2011; 13 (1): 3–11.
11. Danlof B, Sever PS, Poulter NR et al. ASCOT Investigators, Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial, Lancet, 2005, V366, (9489):895-906. 
12. SESA study – Safety and efficacy of S(–) Amlodipine. JAMA–India, 2003, 2 (8): 87–92.
13. Максимова М.А., Лукина Ю.В., Марцевич С.Ю. Роль S-амлодипина в комбинированной терапии артериальной гипертензии антагонистами кальция и бета-блокаторами. Рацион. фармакотерапия в кардиологии. 2013; 9 (3): 236–40.
14. Pitt B, Byington RP, Furberg CD et al. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events, PREVENT Investigators. Circulation 2000; 102: 1503–10.
15. Thadani U. Amlodipine: a once-daily calcium antagonist in the treatment of angina pectoris – a parallel dose response, placebo controlled study. The Amlodipine Study Group. Am Heart J 1989; 118 (5, Pt 2): 1135.
16. Deanfield JE, Detry J-MRG, Lichten PR et al. Amlodipine reduces trancient myocardial ischemia in patients with coronary artery disease: Double-blind circadian anti-ischemia program in Europe (CAPE trial). JACC 1994; 24 (6): 1460–7.
17. Nissen SE, Tuscu EM, Libby P et al for the CAMELOT Investigators. Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure . The CAMELOT Study: A Randomized Controlled Trial. JAMA 2004; 292 (18): 2217–26.
18. Chahine RA, Feldman RL, Gilles TD et al. Randomized placebo-controlled trial of amlodipine in vasospastic angina. JACC 1993; 21 (6): 903–10.
19. Watanabe K, Izumi T, Miyakita Y et al. Efficacy of amlodipine besilate therapy for variant angina: evaluation by 24-hour Holter monitoring. Cardiovasc Drugs Ther 1993; 7 (6): 923–8.

А.Б.Сумароков

Институт клинической кардиологии им А.Л.Мясникова ФГБУ Российский кардиологический научно-производственный комплекс Минздрава России, Москва